Guizhou Yibai Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 572.65 million compared to CNY 683.8 million a year ago. Revenue was CNY 572.65 million compared to CNY 683.8 million a year ago.

Net loss was CNY 68.45 million compared to net income of CNY 44 million a year ago. Basic loss per share from continuing operations was CNY 0.086 compared to basic earnings per share from continuing operations of CNY 0.056 a year ago. Diluted loss per share from continuing operations was CNY 0.086 compared to diluted earnings per share from continuing operations of CNY 0.056 a year ago.